IL144896A0 - Pharmaceutical compositions comprising benzaldehyde derivatives and several such new compounds - Google Patents
Pharmaceutical compositions comprising benzaldehyde derivatives and several such new compoundsInfo
- Publication number
- IL144896A0 IL144896A0 IL14489600A IL14489600A IL144896A0 IL 144896 A0 IL144896 A0 IL 144896A0 IL 14489600 A IL14489600 A IL 14489600A IL 14489600 A IL14489600 A IL 14489600A IL 144896 A0 IL144896 A0 IL 144896A0
- Authority
- IL
- Israel
- Prior art keywords
- several
- pharmaceutical compositions
- new compounds
- benzaldehyde derivatives
- benzaldehyde
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H9/00—Compounds containing a hetero ring sharing at least two hetero atoms with a saccharide radical
- C07H9/02—Compounds containing a hetero ring sharing at least two hetero atoms with a saccharide radical the hetero ring containing only oxygen as ring hetero atoms
- C07H9/04—Cyclic acetals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/18—Acyclic radicals, substituted by carbocyclic rings
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Virology (AREA)
- Immunology (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Rheumatology (AREA)
- Epidemiology (AREA)
- Biochemistry (AREA)
- Tropical Medicine & Parasitology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Dermatology (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
NO990814A NO309305B1 (en) | 1999-02-19 | 1999-02-19 | Use of benzaldehyde derivatives in the manufacture of pharmaceutical preparations for the prevention and / or treatment of cancer, as well as certain new benzaldehyde derivatives |
PCT/NO2000/000060 WO2000048610A1 (en) | 1999-02-19 | 2000-02-18 | Chemical compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
IL144896A0 true IL144896A0 (en) | 2002-06-30 |
Family
ID=19902986
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL14489600A IL144896A0 (en) | 1999-02-19 | 2000-02-18 | Pharmaceutical compositions comprising benzaldehyde derivatives and several such new compounds |
IL14489500A IL144895A0 (en) | 1999-02-19 | 2000-02-18 | Pharmaceutical compositions comprising benzaldehyde derivatives and several such new compounds |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL14489500A IL144895A0 (en) | 1999-02-19 | 2000-02-18 | Pharmaceutical compositions comprising benzaldehyde derivatives and several such new compounds |
Country Status (15)
Country | Link |
---|---|
EP (2) | EP1150690A1 (en) |
JP (2) | JP2002537264A (en) |
CN (2) | CN1347323A (en) |
AU (2) | AU2834100A (en) |
BR (2) | BR0008297A (en) |
CA (2) | CA2362306A1 (en) |
CZ (2) | CZ20012966A3 (en) |
HU (2) | HUP0105281A2 (en) |
IL (2) | IL144896A0 (en) |
MX (2) | MXPA01008346A (en) |
NO (1) | NO309305B1 (en) |
PL (2) | PL350519A1 (en) |
RU (2) | RU2001123035A (en) |
SK (2) | SK11612001A3 (en) |
WO (2) | WO2000048609A1 (en) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002096921A1 (en) * | 2001-05-30 | 2002-12-05 | Nisshin Seifun Group Inc. | Novel glucose derivative inducing apoptosis, process for producing the same, and use thereof as medicine |
DE10261807A1 (en) * | 2002-12-19 | 2004-07-01 | Turicum Drug Development Ag | Deuterated catecholamine derivatives and medicinal products containing these compounds |
CA2615678C (en) * | 2005-07-26 | 2015-01-20 | Nycomed Gmbh | Isotopically substituted pantoprazole |
BRPI0614039A2 (en) * | 2005-07-26 | 2011-03-09 | Nycomed Gmbh | isotopically substituted proton pump inhibitors |
BRPI0617987A2 (en) * | 2005-10-06 | 2011-08-16 | Auspex Pharmaceuticals Inc | composition, pharmaceutical composition, effervescent dosage form, multiple unit oral oral pharmaceutical composition, extended release pharmaceutical dosage form, enteric coated pharmaceutical dosage form, stable pharmaceutical dosage form for oral administration to mammalian subjects, method for treating diseases acid-related diseases by inhibiting gastric acid secretion, method for treating a bacterial infection caused or caused by helicobacter pylori, process for preparing a compound of formula 3, process for preparing a compound of formula 5, use of a compound of formula 1 for the preparation of a medicament for treating gastric acid-related diseases by inhibiting gastric acid secretion, use of a compound of formula 1 for the preparation of a medicament for treating a bacterial infection caused or caused by helicobacter pyl or use of a compound of formula 1 for the preparation of a medicament for treating gastric acid-related diseases by inhibiting gastric acid secretion |
CN101157711B (en) * | 2007-09-28 | 2010-12-08 | 西安交通大学 | Compound having antineoplastic activity and uses thereof |
AU2009251848A1 (en) * | 2008-04-03 | 2009-12-03 | Cognate 3, Llc | Compositions and methods for immunotherapy |
CN101735284B (en) * | 2008-11-24 | 2012-05-23 | 上海医药工业研究院 | Method for preparing 4, 6-O-benzylidene-D-glucopyranose |
KR102373288B1 (en) | 2013-12-03 | 2022-03-10 | 인트라-셀룰라 써래피스, 인코퍼레이티드. | Novel methods |
RU2728787C2 (en) | 2014-04-04 | 2020-07-31 | Интра-Селлулар Терапиз, Инк. | Organic compounds |
JP6898072B2 (en) * | 2015-08-27 | 2021-07-07 | 秀行 佐谷 | 14-3-3 Protein activity regulator |
WO2017165843A1 (en) | 2016-03-25 | 2017-09-28 | Intra-Cellular Therapies, Inc. | Organic compounds |
WO2018071233A1 (en) | 2016-10-12 | 2018-04-19 | Intra-Cellular Therapies, Inc. | Amorphous solid dispersions |
RU2767410C2 (en) | 2017-03-24 | 2022-03-17 | Интра-Селлулар Терапиз, Инк. | New compositions and methods |
AU2019331490A1 (en) | 2018-08-31 | 2021-03-18 | Intra-Cellular Therapies, Inc. | Novel methods |
WO2020047407A1 (en) | 2018-08-31 | 2020-03-05 | Intra-Cellular Therapies, Inc. | Novel methods |
EP4134101A1 (en) | 2019-07-07 | 2023-02-15 | Intra-Cellular Therapies, Inc. | Deuterated lumateperone for the treatment of the bipolar ii disorder |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB811510A (en) * | 1954-12-20 | 1959-04-08 | Gyogyszeripari Ki | New nitrogen-containing derivatives of polyhydroxy compounds and process for the preparation thereof |
JPS6112623A (en) * | 1984-06-28 | 1986-01-21 | Kaken Pharmaceut Co Ltd | Encephalinase inhibiting agent |
JPS6256423A (en) * | 1985-09-06 | 1987-03-12 | Kaken Pharmaceut Co Ltd | Remedy and ameliorating agent for cachexia |
GB8705780D0 (en) * | 1987-03-11 | 1987-04-15 | Norsk Hydro As | Anticancer compounds |
JPH07145191A (en) * | 1993-11-24 | 1995-06-06 | Japan Tobacco Inc | Galactosyl phosphonate derivative |
-
1999
- 1999-02-19 NO NO990814A patent/NO309305B1/en not_active IP Right Cessation
-
2000
- 2000-02-18 IL IL14489600A patent/IL144896A0/en unknown
- 2000-02-18 RU RU2001123035/14A patent/RU2001123035A/en unknown
- 2000-02-18 AU AU28341/00A patent/AU2834100A/en not_active Abandoned
- 2000-02-18 IL IL14489500A patent/IL144895A0/en unknown
- 2000-02-18 CN CN00806488A patent/CN1347323A/en active Pending
- 2000-02-18 WO PCT/NO2000/000059 patent/WO2000048609A1/en not_active Application Discontinuation
- 2000-02-18 EP EP00906782A patent/EP1150690A1/en not_active Withdrawn
- 2000-02-18 SK SK1161-2001A patent/SK11612001A3/en unknown
- 2000-02-18 WO PCT/NO2000/000060 patent/WO2000048610A1/en not_active Application Discontinuation
- 2000-02-18 SK SK1160-2001A patent/SK11602001A3/en unknown
- 2000-02-18 AU AU28342/00A patent/AU2834200A/en not_active Abandoned
- 2000-02-18 JP JP2000599401A patent/JP2002537264A/en active Pending
- 2000-02-18 EP EP00906781A patent/EP1150689A1/en not_active Withdrawn
- 2000-02-18 JP JP2000599400A patent/JP2002537263A/en active Pending
- 2000-02-18 BR BR0008297-0A patent/BR0008297A/en not_active Application Discontinuation
- 2000-02-18 BR BR0008302-0A patent/BR0008302A/en not_active Application Discontinuation
- 2000-02-18 HU HU0105281A patent/HUP0105281A2/en unknown
- 2000-02-18 CA CA002362306A patent/CA2362306A1/en not_active Abandoned
- 2000-02-18 PL PL00350519A patent/PL350519A1/en not_active Application Discontinuation
- 2000-02-18 CZ CZ20012966A patent/CZ20012966A3/en unknown
- 2000-02-18 HU HU0105280A patent/HUP0105280A2/en unknown
- 2000-02-18 RU RU2001123124/15A patent/RU2001123124A/en unknown
- 2000-02-18 CA CA002363670A patent/CA2363670A1/en not_active Abandoned
- 2000-02-18 CN CN00806338A patent/CN1347322A/en active Pending
- 2000-02-18 MX MXPA01008346A patent/MXPA01008346A/en not_active Application Discontinuation
- 2000-02-18 MX MXPA01008347A patent/MXPA01008347A/en not_active Application Discontinuation
- 2000-02-18 CZ CZ20012965A patent/CZ20012965A3/en unknown
- 2000-02-18 PL PL00350520A patent/PL350520A1/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
MXPA01008346A (en) | 2003-06-06 |
NO990814D0 (en) | 1999-02-19 |
CZ20012966A3 (en) | 2002-03-13 |
WO2000048610A1 (en) | 2000-08-24 |
MXPA01008347A (en) | 2004-03-10 |
CA2362306A1 (en) | 2000-08-24 |
AU2834200A (en) | 2000-09-04 |
RU2001123035A (en) | 2004-03-20 |
CZ20012965A3 (en) | 2002-03-13 |
AU2834100A (en) | 2000-09-04 |
CA2363670A1 (en) | 2000-08-24 |
SK11602001A3 (en) | 2002-02-05 |
HUP0105281A2 (en) | 2002-05-29 |
EP1150689A1 (en) | 2001-11-07 |
NO309305B1 (en) | 2001-01-15 |
CN1347323A (en) | 2002-05-01 |
PL350520A1 (en) | 2002-12-16 |
RU2001123124A (en) | 2004-02-20 |
WO2000048609A1 (en) | 2000-08-24 |
BR0008297A (en) | 2002-05-28 |
JP2002537264A (en) | 2002-11-05 |
JP2002537263A (en) | 2002-11-05 |
IL144895A0 (en) | 2002-06-30 |
PL350519A1 (en) | 2002-12-16 |
NO990814L (en) | 2000-08-21 |
HUP0105280A2 (en) | 2002-04-29 |
BR0008302A (en) | 2002-08-27 |
SK11612001A3 (en) | 2002-04-04 |
CN1347322A (en) | 2002-05-01 |
EP1150690A1 (en) | 2001-11-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUP0203378A3 (en) | Pharmaceutical compounds and pharmaceutical compositions containing them | |
HUP0103406A3 (en) | 1h-imidazopyridine derivatives and pharmaceutical compositions thereof | |
IL152451A0 (en) | 2-chloro-2-nitrophenylcarboxamide derivatives and pharmaceutical compositions containing the same | |
HUP0301178A3 (en) | Glucopyranosyloxybenzylbenzene derivatives and pharmaceutical compositions containing the same | |
HUP0203939A3 (en) | Pharmaceutical compounds and compositions containing them and their use | |
IL153123A0 (en) | N-ureidoheterocycloalkyl-piperidine derivatives and pharmaceutical compositions containing the same | |
HUP0103256A3 (en) | Thiobenzimidazole derivatives and pharmaceutical compositions containing the compounds | |
HUP0200714A3 (en) | Pharmaceutical compounds, pharmaceutical compositions containing them and their use | |
HUP0102990A3 (en) | Tetrahydroimidazo-naphtyridine derivatives and pharmaceutical compositions thereof | |
HUP0301269A3 (en) | Phthalazinone derivatives and pharmaceutical compositions containing them | |
PL351387A1 (en) | Pharmaceutical composition | |
HUP0200155A2 (en) | Thioamide derivatives, pharmaceutical compositions containing them and their use | |
HUP0201334A3 (en) | Hydrochloride of fused-heterocycle compound and pharmaceutical compositions containing the same | |
IL144895A0 (en) | Pharmaceutical compositions comprising benzaldehyde derivatives and several such new compounds | |
IL147214A0 (en) | 1-methylcarbapenem derivatives and pharmaceutical compositions containing the same | |
HUP0103203A3 (en) | Azaadamantane derivatives and pharmaceutical compositions thereof | |
HUP0105204A3 (en) | Substituted phenethylamine derivatives and pharmaceutical compositions containing them | |
IL137415A0 (en) | Cyclobutene derivatives and pharmaceutical compositions containing the same | |
HUP0303184A3 (en) | Substituted c-cyclohexylmethylamine derivatives and pharmaceutical compositions containing them | |
HUP0200747A2 (en) | Pharmaceutical compounds and pharmaceutical compositions containing them | |
HUP0203839A3 (en) | 4-phenyl-1-piperazinyl, -piperidinyl and -tetrahydropyridyl derivatives, pharmaceutical compositions containing them and their use | |
HUP0303204A3 (en) | 1-methylcarbapenem derivatives and pharmaceutical compositions containing them | |
GB9803521D0 (en) | New compounds and pharmaceutical compositions thereof | |
IL156372A0 (en) | Carbazole derivatives and pharmaceutical compositions containing the same | |
HUP0201443A3 (en) | 1-trifluoromethyl-4-hydroxy-7-piperidinyl-aminomethylchroman derivatives and pharmaceutical compositions containing them |